After canceling an ethically dubious trial, NIH sticks with a muddled message on booze
Reason number 1,001 to slow down when reporting on breaking health news
The Cancer Moonshot: A perspective in 4 graphs
Predictions for Precision Medicine get an evidence-based reality check
“Low T” tease: rosy anecdotes and the reality of testosterone treatment effects
Precision Medicine at one year: A soaring White House summit and the potholes ahead
Informed patients need one thing not provided in SPRINT trial news: what were the absolute benefit/harm numbers?
Do published SPRINT study results live up to premature NIH news release hype?
NIH SPRINT study sparks questions about overtreatment of mild hypertension